Hypertension as a surrogate marker for the activity of anti-VEGF agents

被引:43
作者
Mir, O. [1 ]
Ropert, S.
Alexandre, J.
Goldwasser, F.
机构
[1] Univ Paris 05, Teaching Hosp Cochin, Ctr Res & Study Angiogenesis Inhibitors CERIA, AP HP, Paris, France
关键词
ENDOTHELIAL GROWTH-FACTOR; ARTERIAL-HYPERTENSION; COLORECTAL-CANCER; BEVACIZUMAB; METAANALYSIS; SUNITINIB; SORAFENIB; RISK;
D O I
10.1093/annonc/mdp206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:967 / 970
页数:4
相关论文
共 18 条
[1]   Home blood-pressure monitoring in patients receiving sunitinib [J].
Azizi, Michel ;
Chedid, Antoine ;
Oudard, Stephane .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :95-97
[2]  
ESCUDLER BJ, 2008, J CLIN ONCOL S 1, V26
[3]  
FRIBERG G, 2005, J CLIN ONCOL 1, V23
[4]   Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: A review of 246 cases [J].
Henriksen, Kanuni J. ;
Meehan, Shane M. ;
Chang, Anthony .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (11) :1703-1708
[5]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
[6]  
Maitland M L., 2006, J Clin Oncol, V24, P2035, DOI DOI 10.1200/JCO.2006.24.18_SUPPL.2035
[7]   2007 ESH-ESC practice guidelines for the management of arterial hypertension - ESH-ESC task force on the management of arterial hypertension [J].
Mancia, Giuseppe ;
De Backer, Guy ;
Dominiczak, Anna ;
Cifkova, Renata ;
Fagarde, Robert ;
Germanof, Giuseppe ;
Grassi, Guido ;
Heagertyh, Anthony M. ;
Kjeldsen, Sverre E. ;
Laurenti, Stephanie ;
Narkiewicz, Krzysztof ;
Ruilopel, Luis ;
Rynkiewicz, Andrzej ;
Schmiedern, Roland E. ;
Boudiero, Harry A. J. Struijker ;
Zanchetti, Alberto .
JOURNAL OF HYPERTENSION, 2007, 25 (09) :1751-1762
[8]  
RINI BI, 2008, J CLIN ONCOL 1, V26
[9]   Quantifying hypertension in patients with cancer treated with sorafenib [J].
Rini, Brian I. .
LANCET ONCOLOGY, 2008, 9 (02) :86-87
[10]   Hypertension as a predictive factor of Sunitinib activity [J].
Rixe, O. ;
Billemont, B. ;
Izzedine, H. .
ANNALS OF ONCOLOGY, 2007, 18 (06) :1117-1117